1-3 of 3
Andreas Feldges
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Clinical Trials & Observations
Anja Möricke, Alfred Reiter, Martin Zimmermann, Helmut Gadner, Martin Stanulla, Michael Dördelmann, Lutz Löning, Rita Beier, Wolf-Dieter Ludwig, Richard Ratei, Jochen Harbott, Joachim Boos, Georg Mann, Felix Niggli, Andreas Feldges, Günter Henze, Karl Welte, Jörn-Dirk Beck, Thomas Klingebiel, Charlotte Niemeyer, Felix Zintl, Udo Bode, Christian Urban, Helmut Wehinger, Dietrich Niethammer, Hansjörg Riehm, Martin Schrappe
Journal: Blood
Blood (2008) 111 (9): 4477–4489.
https://doi.org/10.1182/blood-2007-09-112920
Published: 2008
Includes: Supplemental data
Journal Articles

Increased Lipoprotein(a) levels are not a steady prothrombotic defect

Wolfgang Korte, Jeanette Greiner, Andreas Feldges, Walter F. Riesen
Journal: Blood
Blood (2001) 98 (6): 1993–1994.
https://doi.org/10.1182/blood.V98.6.1993
Published: 2001
Journal Articles

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90

Clinical Trials & Observations
Martin Schrappe, Alfred Reiter, Wolf-Dieter Ludwig, Jochen Harbott, Martin Zimmermann, Wolfgang Hiddemann, Charlotte Niemeyer, Günter Henze, Andreas Feldges, Felix Zintl, Bernhard Kornhuber, Jörg Ritter, Karl Welte, Helmut Gadner, Hansjörg Riehm
Journal: Blood
Blood (2000) 95 (11): 3310–3322.
https://doi.org/10.1182/blood.V95.11.3310
Published: 2000